Singapore Mpox Vaccine: Protection, Safety, and Who Should Get Vaccinated

The Singapore mpox vaccine is an important preventive measure against monkeypox (mpox), a viral infection that can spread through close physical contact. With global outbreaks and sporadic cases reported in Singapore, vaccination has become a key tool in reducing transmission, protecting high-risk populations, and minimizing severe illness.

This SEO-friendly guide explains the Singapore mpox vaccine, including its types, effectiveness, safety, eligibility, and preventive measures.

What Is the Singapore Mpox Vaccine?

The Singapore mpox vaccine protects against the monkeypox virus. Since mpox is related to smallpox, vaccines originally developed for smallpox also provide immunity against mpox.

The vaccine helps:

  • Lower the risk of infection

  • Reduce the severity of symptoms

  • Prevent complications

  • Limit transmission in communities

The Ministry of Health (MOH) Singapore oversees vaccination programs and ensures access for individuals at higher risk.

Types of Mpox Vaccines in Singapore

Singapore uses two primary vaccines for mpox prevention:

1. JYNNEOS (MVA-BN)

JYNNEOS is the preferred vaccine due to its safety profile.

Features:

  • Non-replicating vaccine (cannot reproduce in the body)

  • Administered in two doses, four weeks apart

  • Safe for individuals with weakened immune systems

  • Low risk of serious side effects

2. ACAM2000

ACAM2000 is an older smallpox vaccine that also provides protection against mpox.

Features:

  • Live, replicating vaccine

  • Single-dose administration

  • Higher risk of side effects

  • Not suitable for individuals with certain health conditions

ACAM2000 is used selectively for high-risk cases due to safety concerns.

Effectiveness of the Singapore Mpox Vaccine

Smallpox-based vaccines are around 85% effective in preventing monkeypox infection. Vaccination helps reduce:

  • The likelihood of contracting mpox

  • Severity of symptoms if infected

  • Duration of illness

  • Risk of hospitalization

Even if a vaccinated person contracts mpox, symptoms are usually milder and recovery is faster.

Who Should Get Vaccinated in Singapore?

Vaccination is recommended for:

  • Close contacts of confirmed mpox cases

  • Healthcare workers treating mpox patients

  • Laboratory personnel handling orthopoxviruses

  • Individuals deemed high-risk by the Ministry of Health (MOH) Singapore

Routine vaccination of the general public is generally not necessary unless advised during an outbreak.

Post-Exposure Vaccination

The Singapore mpox vaccine can be effective even after exposure:

  • Within 4 days of exposure: may prevent infection

  • Within 14 days of exposure: may reduce symptom severity

Prompt consultation with a healthcare provider is crucial for post-exposure vaccination.

Safety and Side Effects

The Singapore mpox vaccine is generally safe, especially non-replicating vaccines like JYNNEOS.

Common side effects:

  • Redness or swelling at the injection site

  • Mild fever

  • Fatigue

  • Headache

  • Muscle aches

Side effects are typically mild and resolve within a few days. Serious complications are rare. ACAM2000 carries a higher risk of side effects and is used only in specific high-risk cases.

How the Vaccine Is Administered

  • JYNNEOS: Two injections under the skin, four weeks apart

  • ACAM2000: Single dose using a specialized skin-prick method

Full protection develops approximately two weeks after completing the vaccination schedule.

Who Should Consult a Doctor Before Vaccination?

Individuals should seek medical advice if they:

  • Have severe allergies to vaccine ingredients

  • Have weakened immune systems

  • Are pregnant or breastfeeding

  • Have chronic medical conditions

Healthcare providers in Singapore can recommend the safest vaccination option.

Importance of the Singapore Mpox Vaccine

Vaccination plays a crucial role in controlling mpox outbreaks in Singapore. It helps:

  • Protect high-risk populations

  • Reduce community transmission

  • Minimize severity of illness

  • Support outbreak containment

When combined with hygiene practices and avoiding close contact with symptomatic individuals, vaccination significantly lowers the risk of mpox.

Conclusion

The Singapore mpox vaccine is a safe and effective way to prevent monkeypox infection and reduce the severity of illness. Targeted vaccination for high-risk groups ensures maximum protection while minimizing unnecessary exposure.

Published
Categorized as Journal